VAP, HEOR and Strategy Access Sr Manager at Bristol-Myers Squibb

Sao Paulo, Sao Paulo, Brazil

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

10+ years of pharmaceutical experience, with commercial experience preferred
2+ years of people management experience preferred
5+ years of experience managing a portfolio of brands in different points of their life cycle (launch, grow, mature)
Experience launching new products or new indications
Knowledge on HEOR and Market Access
Experience and/or Knowledge on Oncology studies
Experience on Project Management
Understanding about Health Market Data
Understanding Clinical Data and interpretation of Clinical Outcomes measurements
Excellence on Communication and presentation abilities
Abilities in develop relationships with Key Healthcare Stakeholders including Payers and Medical Services
Success in effectively communicating and influencing decisions with senior management
Ability to "flex" across different types of cultures, work, complexities, business situations and proven ability to work with matrix partners
Understanding of regulatory policies and impact of public relations in Brazilian Market
Demonstrated ability to successfully and effectively collaborate and work across boundaries (e.g. disease mgt., marketing, external development) and building strong external relationships
Demonstrated use of communication and change management strategies/tactics to champion new ways of thinking and working
Fully bilingual, Portuguese and English
Able to deliver against commercial and broader performance objectives
Fluency in analytical models (e.g., journey decisioning engine) and ability to translate analytics from BI&A teams into actionable strategies

Responsibilities

Defining, building, and implementing market access strategies for BMS products in both public and private sectors, ensuring patient access to the company’s medicines
Acting as a strategic leader, technical reference, and connector among multifunctional areas (Market Access, HEOR, Pricing, Medical, Marketing, Government Affairs, Field Access)
Promoting integration, stakeholder engagement, and tactical execution aligned with brand and company objectives
Ensuring the execution of access strategy through Health Technology Assessment (HTA) processes
Disseminating value messages
Identifying HEOR opportunities

Skills

Market Access Strategy

HEOR

Pricing Strategy

Stakeholder Engagement

Government Affairs

Strategic Leadership

Patient Access

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free